Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Medicinova Inc (MNOV)  
$1.40 0.07 (4.76%) as of 4:30 Tue 6/4


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 44,930,000
Market Cap: 62.90(M)
Last Volume: 19,930 Avg Vol: 310,930
52 Week Range: $1.28 - $2.6
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   MediciNova is a biopharmaceutical company. Co. is focusing its development activities on MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, substance dependence and addiction and prevention of acute respiratory distress syndrome, and MN-001 (tipelukast) for fibrotic diseases such as nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis. Co.'s pipeline also includes MN-221 (bedoradrine) for the treatment of acute exacerbation of asthma and MN-029 (denibulin) for solid tumor cancers.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 12,646
Total Sell Value $0 $0 $0 $28,031
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 4
End Date 2024-03-07 2023-12-05 2023-06-06 2022-06-06

   
Records found: 89
  Page 2 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Iwaki Yuichi President and CEO   •       •      –    2018-01-03 4 OE $4.42 $235,864 D/D 53,363 690,591     -
   Okajima Masatsune VP and Head of Japanese Office   •       –      –    2017-12-12 4 OE $4.42 $212,160 D/D 48,000 108,941     -
   Iwaki Yuichi President and CEO   •       •      –    2017-11-02 4 OE $4.42 $93,116 D/D 21,067 637,228     -
   Ishizaka Yoshio Director   –       •      –    2017-08-21 4 B $5.17 $25,850 I/I 5,000 10,000 2.1     -
   Kobayashi Yutaka Director   –       •      –    2017-05-15 4 B $5.60 $5,600 I/I 1,000 25,000 2.1     -
   Kobayashi Yutaka Director   –       •      –    2017-05-12 4 B $5.62 $134,880 I/I 24,000 24,000 2.1     -
   Kobayashi Yutaka Director   –       •      –    2016-09-15 4 B $6.44 $75,992 D/D 11,800 81,800 2.39     -
   Kobayashi Yutaka Director   –       •      –    2016-09-09 4 B $6.67 $66,700 D/D 10,000 70,000 2.39     -
   Obrien Geoffrey Vice President   •       –      –    2016-07-05 4 AS $8.00 $26,400 D/D (3,300) 5,000     -
   Obrien Geoffrey Vice President   •       –      –    2016-07-05 4 OE $4.80 $15,840 D/D 3,300 8,300     -
   Matsuda Kazuko Chief Medical Officer   •       –      –    2016-03-14 4 OE $3.56 $2,848 D/D 800 62,003     -
   Okajima Masatsune VP and Head of Japanese Office   •       –      –    2016-03-14 4 OE $3.56 $29,904 D/D 8,400 51,138     -
   Kobayashi Yutaka Director   –       •      –    2014-12-10 4 B $3.54 $42,480 D/D 12,000 60,000 2.39     -
   Kobayashi Yutaka Director   –       •      –    2014-11-26 4 B $3.07 $30,700 D/D 10,000 48,000 2.39     -
   Kobayashi Yutaka Director   –       •      –    2014-11-20 4 B $3.19 $41,470 D/D 13,000 38,000 2.39     -
   Ishizaka Yoshio Director   –       •      –    2014-11-19 4 B $2.86 $14,300 I/I 5,000 5,000 2.1     -
   Kobayashi Yutaka Director   –       •      –    2014-09-11 4 B $2.95 $29,500 D/D 10,000 25,000 2.39     -
   Kobayashi Yutaka Director   –       •      –    2014-09-03 4 B $2.63 $39,849 D/D 15,000 15,000 2.39     -
   Ishizaka Yoshio Director   –       •      –    2014-04-08 3 IO $0.00 $0 D/D 0 5,000     -
   Izumi Tatsuo Director   –       •      –    2013-12-12 4 S $2.10 $149,946 D/D (71,270) 600,000     -
   Izumi Tatsuo Director   –       •      –    2013-11-18 4 B $2.21 $2,812 D/D 1,270 671,270 2.31     -
   Obrien Geoffrey Vice PresidentOfficer   •       –      –    2013-10-15 3 IO $0.00 $0 D/D 0 5,000     -
   Morris Arlene Director   –       •      –    2013-05-21 4 S $3.28 $28,877 D/D (8,800) 0     -
   Morris Arlene Director   –       •      –    2013-05-21 4 OE $2.40 $21,490 D/D 8,800 8,800     -
   Satomi Hajime 10% Owner   –       –       •   2013-05-13 3 IO $0.00 $0 I/I 0 1,000,000     -
  89 Records found
  1  2  3  4   
  Page 2 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us